Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morel

Showing results (781-790 of 834) with videos related to

Pageof 84
Sort By:
Blood|August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomasC Adida, C Haioun, P Gaulard, et al.
Revue Medicale Suisse|July 24, 2014
[Cell transplantation: current treatments and future prospects]R P H Meier, Y D Muller, E M Gutzwiller, et al.
Annals of Surgery|September 1, 1989
A 10-year experience with 290 pancreas transplants at a single institutionD E Sutherland, D L Dunn, F C Goetz, et al.
Haematologica|May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'AdulteR O Casasnovas, C Haioun, C Dumontet, et al.
Transplantation Proceedings|February 1, 1991
Donor age and cause of death affect cadaver renal allograft outcomeC Troppmann, P S Almond, F S Escobar, et al.
Transplantation|January 1, 1991
Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcomeD L Dunn, P Morel, R Schlumpf, et al.
La Revue De Medecine Interne|April 6, 2010
[Waldenström's macroglobulinemia]S Poulain, M Wemeau, S Balkaran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patientsC Haioun, N Mounier, B Quesnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte studyC Haioun, E Lepage, C Gisselbrecht, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|June 16, 2001
[Multidisciplinary management of hereditary colorectal cancer]C Soravia, C Delozier-Blanchet, J L Blouin, et al.
Pageof 84

Showing results (781-790 of 834) with videos related to

Sort By:
Pageof 84
Blood|August 29, 2000
Prognostic significance of survivin expression in diffuse large B-cell lymphomasC Adida, C Haioun, P Gaulard, et al.
Revue Medicale Suisse|July 24, 2014
[Cell transplantation: current treatments and future prospects]R P H Meier, Y D Muller, E M Gutzwiller, et al.
Annals of Surgery|September 1, 1989
A 10-year experience with 290 pancreas transplants at a single institutionD E Sutherland, D L Dunn, F C Goetz, et al.
Haematologica|May 9, 2000
Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'AdulteR O Casasnovas, C Haioun, C Dumontet, et al.
Transplantation Proceedings|February 1, 1991
Donor age and cause of death affect cadaver renal allograft outcomeC Troppmann, P S Almond, F S Escobar, et al.
Transplantation|January 1, 1991
Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcomeD L Dunn, P Morel, R Schlumpf, et al.
La Revue De Medecine Interne|April 6, 2010
[Waldenström's macroglobulinemia]S Poulain, M Wemeau, S Balkaran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patientsC Haioun, N Mounier, B Quesnel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte studyC Haioun, E Lepage, C Gisselbrecht, et al.
Swiss Surgery = Schweizer Chirurgie = Chirurgie Suisse = Chirurgia Svizzera|June 16, 2001
[Multidisciplinary management of hereditary colorectal cancer]C Soravia, C Delozier-Blanchet, J L Blouin, et al.
Pageof 84